Stay updated on Brentuximab & Nivolumab for Early Hodgkin Lymphoma Clinical Trial

Sign up to get notified when there's something new on the Brentuximab & Nivolumab for Early Hodgkin Lymphoma Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the Brentuximab & Nivolumab for Early Hodgkin Lymphoma Clinical Trial page

  1. Check
    yesterday
    No Change Detected
  2. Check
    9 days ago
    Change Detected
    Summary
    - Page version updated from v3.4.2 to v3.4.3.
    Difference
    0.0%
    Check dated 2026-03-07T19:16:55.000Z thumbnail image
  3. Check
    16 days ago
    No Change Detected
  4. Check
    30 days ago
    Change Detected
    Summary
    Revision updated from v3.4.1 to v3.4.2, a minor update that does not affect core content or functionality. To avoid being alerted by small changes, set an alert condition by clicking below.
    Difference
    0.1%
    Check dated 2026-02-14T04:04:05.000Z thumbnail image
  5. Check
    37 days ago
    Change Detected
    Summary
    A new site revision label appears: Revision: v3.4.1 replaces Revision: v3.4.0. To avoid being alerted by small changes, set an alert condition by clicking below.
    Difference
    0.1%
    Check dated 2026-02-07T00:47:25.000Z thumbnail image
  6. Check
    52 days ago
    Change Detected
    Summary
    Additions include UI labels Show glossary and Hide glossary, plus policy/version text: Last Update Submitted that Met QC Criteria; No FEAR Act Data; Revision: v3.4.0. Deletions include Last Update Submitted that met QC Criteria; No FEAR Act data; Revision: v3.3.4.
    Difference
    0.2%
    Check dated 2026-01-23T18:11:50.000Z thumbnail image
  7. Check
    59 days ago
    Change Detected
    Summary
    Revision updated from v3.3.3 to v3.3.4 with no substantive changes. To avoid being alerted by small changes, set an alert condition by clicking below.
    Difference
    0.0%
    Check dated 2026-01-16T12:00:32.000Z thumbnail image
  8. Check
    88 days ago
    Change Detected
    Summary
    A centralized Locations section has been added listing all study sites by state (Alabama, California, Georgia, Illinois, Massachusetts, New Jersey, New York, Ohio, Pennsylvania, Tennessee, Texas, Utah). Removed individual state location subsections and applied revision v3.3.3.
    Difference
    1%
    Check dated 2025-12-18T21:35:04.000Z thumbnail image

Stay in the know with updates to Brentuximab & Nivolumab for Early Hodgkin Lymphoma Clinical Trial

Enter your email address, and we'll notify you when there's something new on the Brentuximab & Nivolumab for Early Hodgkin Lymphoma Clinical Trial page.